Search research articles
Contact Us
Filters
Showing results (41-50 of 202) with videos related to
Page
of 21
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 2, 2012
Third generation anti-citrullinated peptide antibody assay is a sensitive marker in rheumatoid factor negative rheumatoid arthritis
Andreas Swart, Rufus W Burlingame, Irmgard Gürtler, et al.
Current Medicinal Chemistry
|
November 30, 2007
Synthetic peptides: the future of patient management in systemic rheumatic diseases?
Kai Kessenbrock, Reinout Raijmakers, Marvin J Fritzler, et al.
Arthritis Research & Therapy
|
July 21, 2007
Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus
Michael Mahler, Aderajew Waka, F Hiepe, et al.
Journal of Immunology Research
|
September 25, 2018
Two-Parametric Immunological Score Development for Assessing Renal Involvement and Disease Activity in Systemic Lupus Erythematosus
Christopher Sjöwall, Chelsea Bentow, Mary Ann Aure, et al.
Journal of Immunology Research
|
August 7, 2014
Autoantibodies in systemic autoimmune disorders
Michael Mahler, Silvia Pierangeli, Pier-Luigi Meroni, et al.
Rheumatology International
|
April 2, 2013
Is there an association between Ro52/TRIM21 antibodies and rheumatoid factor in systemic sclerosis?
Sonal Mehra, Marie Hudson, Michael Mahler, et al.
Journal of Immunology Research
|
May 29, 2014
Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies
Michael Mahler, Pier-Luigi Meroni, Xavier Bossuyt, et al.
Autoimmunity Reviews
|
June 2, 2012
Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome
Michael Mahler, Gary L Norman, Pier Luigi Meroni, et al.
Clinical Reviews in Allergy & Immunology
|
June 29, 2016
The Clinical Relevance of Anti-DFS70 Autoantibodies
Karsten Conrad, Nadja Röber, Luis E C Andrade, et al.
Frontiers in Immunology
|
June 14, 2021
Autoantibody Discovery, Assay Development and Adoption: Death Valley, the Sea of Survival and Beyond
Marvin J Fritzler, May Y Choi, Minoru Satoh, et al.
Page
of 21
Search research articles
Search
Showing results (41-50 of 202) with videos related to
Sort By:
Page
of 21
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 2, 2012
Third generation anti-citrullinated peptide antibody assay is a sensitive marker in rheumatoid factor negative rheumatoid arthritis
Andreas Swart, Rufus W Burlingame, Irmgard Gürtler, et al.
Current Medicinal Chemistry
|
November 30, 2007
Synthetic peptides: the future of patient management in systemic rheumatic diseases?
Kai Kessenbrock, Reinout Raijmakers, Marvin J Fritzler, et al.
Arthritis Research & Therapy
|
July 21, 2007
Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus
Michael Mahler, Aderajew Waka, F Hiepe, et al.
Journal of Immunology Research
|
September 25, 2018
Two-Parametric Immunological Score Development for Assessing Renal Involvement and Disease Activity in Systemic Lupus Erythematosus
Christopher Sjöwall, Chelsea Bentow, Mary Ann Aure, et al.
Journal of Immunology Research
|
August 7, 2014
Autoantibodies in systemic autoimmune disorders
Michael Mahler, Silvia Pierangeli, Pier-Luigi Meroni, et al.
Rheumatology International
|
April 2, 2013
Is there an association between Ro52/TRIM21 antibodies and rheumatoid factor in systemic sclerosis?
Sonal Mehra, Marie Hudson, Michael Mahler, et al.
Journal of Immunology Research
|
May 29, 2014
Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies
Michael Mahler, Pier-Luigi Meroni, Xavier Bossuyt, et al.
Autoimmunity Reviews
|
June 2, 2012
Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome
Michael Mahler, Gary L Norman, Pier Luigi Meroni, et al.
Clinical Reviews in Allergy & Immunology
|
June 29, 2016
The Clinical Relevance of Anti-DFS70 Autoantibodies
Karsten Conrad, Nadja Röber, Luis E C Andrade, et al.
Frontiers in Immunology
|
June 14, 2021
Autoantibody Discovery, Assay Development and Adoption: Death Valley, the Sea of Survival and Beyond
Marvin J Fritzler, May Y Choi, Minoru Satoh, et al.
Page
of 21